Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the …
…, DE Furst, LW Moreland, MH Weisman… - Arthritis & …, 2003 - Wiley Online Library
Objective To evaluate the efficacy and safety of adalimumab (D2E7), a fully human monoclonal
tumor necrosis factor α antibody, in combination with methotrexate (MTX) in patients with …
tumor necrosis factor α antibody, in combination with methotrexate (MTX) in patients with …
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
…, H Fang, N Pham, R Brey, MH Weisman… - Arthritis & …, 2012 - Wiley Online Library
Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…
The PREMIER study: a multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or …
FC Breedveld, MH Weisman… - … : Official Journal of …, 2006 - Wiley Online Library
Objective To compare the efficacy and safety of adalimumab plus methotrexate (MTX)
versus MTX monotherapy or adalimumab monotherapy in patients with early, aggressive …
versus MTX monotherapy or adalimumab monotherapy in patients with early, aggressive …
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
, … Ivan 23 O'Donovan Michael C 23 Owen Michael J 23 … - Nature …, 2007 - nature.com
We have genotyped 14,436 nonsynonymous SNPs (nsSNPs) and 897 major histocompatibility
complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), …
complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), …
[HTML][HTML] Infliximab and methotrexate in the treatment of rheumatoid arthritis
…, JR Kalden, JS Smolen, M Weisman… - … England Journal of …, 2000 - Mass Medical Soc
Background Neutralization of tumor necrosis factor α (TNF-α) for three to six months reduces
the symptoms and signs of rheumatoid arthritis. However, the capacity of this approach to …
the symptoms and signs of rheumatoid arthritis. However, the capacity of this approach to …
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a …
…, F Breedveld, D Furst, J Kalden, M Weisman… - The Lancet, 1999 - thelancet.com
Background Not all patients with rheumatoid arthritis can tolerate or respond to methotrexate,
a standard treatment for this disease. There is evidence that antitumour necrosis factor α (…
a standard treatment for this disease. There is evidence that antitumour necrosis factor α (…
[HTML][HTML] Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
…, CO Bingham III, MH Weisman… - … England Journal of …, 2006 - Mass Medical Soc
Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …
multicenter, double-blind, placebo- and celecoxib-controlled Glucosamine/chondroitin Arthritis …
[HTML][HTML] Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
…, GS Gilkeson, DJ Wallace, MH Weisman… - … England Journal of …, 2005 - Mass Medical Soc
Background Since anecdotal series and small, prospective, controlled trials suggest that
mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are desirable. …
mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are desirable. …
New therapies for treatment of rheumatoid arthritis
JS Smolen, D Aletaha, M Koeller, MH Weisman… - The lancet, 2007 - thelancet.com
Rheumatoid arthritis is characterised by pain, swelling, and destruction of joints, with
resultant disability. Only disease-modifying antirheumatic drugs can interfere with the disease …
resultant disability. Only disease-modifying antirheumatic drugs can interfere with the disease …
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility
…, T Karaderi, GP Thomas, MM Ward, MH Weisman… - Nature …, 2011 - nature.com
Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting
the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. …
the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. …